NCT01087242

Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus

Randomized，Double-blind，Dose Parallel Controlled, Multicentre Clinical Trail of Tang-min-Ling Pills and Placebo in Diabetes Mellitus(Liver-stomach Heat Retention Syndrome) (Phase Ⅲ)

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 480 (estimated)
• Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 30 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, doubled blind, dose-paralleled control, multi-centre clinical trail,to evaluate the efficacy of Tang-min-ling pills in the treatment of type 2 diabetes mellitus.

Detailed description

Type 2 diabetes mellitus combined liver-stomach heat retension syndrome were recruited, which were divided into 3 groups .The patients were randomly taken with high-dosage (12g Tang-min-ling pills every time), low-dosage (6g Tang-min-ling pills every time), placebo by 3 times every day for 12 weeks.

Conditions

• Type 2 Diabetes

Interventions

Type	Name	Description
DRUG	Tang-min Lin pill	Tang-min Lin pill 6g,tid,treat 12 weeks.

Timeline

• Start date: 2009-05-01
• Primary completion: 2009-12-01
• Completion: 2010-06-01
• First posted: 2010-03-16
• Last updated: 2010-03-16

Locations

4 sites across 1 country: China